News

AS Tallink Grupp Reports Decrease in Q3 2024 Figures

AS Tallink Grupp Reports Decrease in Q3 2024 Figures

Insights into AS Tallink Grupp's Q3 2024 Performance

Recently, AS Tallink Grupp revealed its unaudited consolidated interim report for Q3 2024, summarizing the company's performance and challenges faced during the period.

Passenger and Revenue Trends

In the third quarter, spanning from July to September, AS Tallink Grupp transported about 1,715,496 passengers. This figure reflects a 3.4% decrease compared to the same quarter in 2023. Passenger vehicle transport also took a hit, falling by 8.3%, resulting in 250,810 vehicles carried. Cargo volume was not spared either, decreasing by 11.7% year-on-year.

Total revenue for the Group stood at EUR 231.9 million, a drop from EUR 240.7 million in Q3 2023, marking a 3.7% decrease. The unaudited net profit for the quarter amounted to EUR 36.8 million, which is down from EUR 48.7 million in the prior year's Q3.

Operational Challenges Impacting Results

The decline in revenue and passenger numbers can be attributed to multiple factors affecting the organization:

  • Consumer and business confidence levels remained low, influenced by broader economic challenges and geopolitical tensions within core markets.
  • The fleet remained operational with 14 vessels at the end of the quarter, including a mix of shuttle and cargo vessels, alongside chartered and laid-up ships.
  • Operational adjustments included the return of the cruise ferry Victoria I to the Tallinn-Helsinki route as of the end of August.
  • The Group maintained three hotels across two cities, with continued focus on maximizing efficiency through cost control measures.
  • As of September end, the Group's net debt reached EUR 555.7 million, showing an increase from the previous quarter, while the net debt to EBITDA ratio rose to 2.98.
  • Dividend payouts amounted to EUR 44.6 million with associated tax expenses influencing cash reserves.
  • Shareholding composition shifted significantly with AS Infortar increasing its stake from 46.8% to 68.5%.
  • Ongoing evaluations of operational routes are being conducted to optimize profitability and explore potential charter opportunities.

Revenue Insights by Route Operations

The operational segments showed varied results:

  • Revenue from the core operations fell by EUR 2.0 million to EUR 193.6 million, with the segment reporting a result of EUR 48.1 million, down by EUR 6.9 million.
  • Insights from specific routes highlighted a 1.7% decline in the Estonia-Finland passenger numbers, with cargo units down by 13.0%, even though revenues slightly improved by EUR 0.4 million.
  • Intense competition led to an 18.1% drop in passenger numbers on the Finland-Sweden routes, where revenue fell by EUR 11.1 million.
  • Contrastingly, the Estonia-Sweden routes saw an increase in passengers by 34.2%, albeit cargo units declined by 21.6%; overall revenue in this segment rose to EUR 34.2 million.
  • The segment labeled 'Other' posted a revenue decline of EUR 7.2 million due to a reduced number of chartered vessels.

Financial Performance Overview

In Q3 2024, gross profit decreased to EUR 67.0 million, from EUR 77.7 million year-on-year. The adjusted EBITDA also suffered a decline, hitting EUR 68.4 million versus EUR 82.1 million in the previous year.

As the company continues to address the ongoing economic pressures and reevaluate its operational strategies, notable investments of EUR 5.6 million were made during the quarter for maintenance and upgrades of assets, demonstrating a commitment to improving service and efficiency. These investments also included enhancements to IT systems to strengthen operational capabilities.

Future Outlook and Dividend Policy

AS Tallink Grupp's long-term strategy includes retaining its dividend policy, established in 2018, which stipulates a minimum payout of EUR 0.05 per share based on financial performance. The resolution to distribute EUR 0.06 per share for the 2023 financial year was passed recently, indicating intent to reward shareholders as performance stabilizes.

As the Group heads into the final quarter of the financial year, it faces ongoing challenges related to market conditions but remains focused on cost efficiencies and maintaining a competitive edge in its core routes.

Frequently Asked Questions

1. What were the passenger figures for AS Tallink Grupp in Q3 2024?

AS Tallink Grupp carried approximately 1,715,496 passengers in Q3 2024, marking a 3.4% decrease from Q3 2023.

2. How did the financial performance compare to last year?

Total revenue for Q3 2024 decreased to EUR 231.9 million, down from EUR 240.7 million in Q3 2023.

3. What factors influenced the decrease in revenue?

Key factors include low consumer confidence and geopolitical tensions impacting core markets, alongside operational changes within the fleet.

4. What is the current net debt of AS Tallink Grupp?

As of the end of Q3 2024, the Group's net debt amounted to EUR 555.7 million.

5. Is AS Tallink Grupp planning to pay dividends for the 2023 financial year?

Yes, the Group has declared a dividend of EUR 0.06 per share for the financial year of 2023.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

VAB's Pharma Ad Guide: Emerging Trends and Insights

Updated Category News Views 191

Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...

Continue Reading
Silvercorp Updates El Domo Budget Amid Challenges

Updated Category News Views 47

Budget Pains for Silvercorp's El Domo Project Folks, if you thought navigating the stock market was a minefield, try mining these days. Silvercorp Metals Inc. had to bump up its budget for the El Domo project in Ecuador—again. This time by $14.6 million. What's causing this fiscal heartache? Everything from rising diesel prices thanks to Ecuador playing games with...

Continue Reading
Rising Medical Lands Ninth Spot on Inc. 5000

Updated Category News Views 144

Rising Medical's Continued Ascent In a world where the list of high-performing companies is as long as a trader's bad day, Rising Medical Solutions, out of Chicago, has snagged its ninth appearance on the Inc. 5000 list. This isn’t just any roll call; we're talking about a spotlight for America’s fastest-growing private companies—a badge of honor for business...

Continue Reading
Elanco Heads to UBS Global Healthcare—What Matters

Updated Category News Views 48

Elanco's Strategy Under the Spotlight at UBS Confab Right off the bat, let's chew over why Elanco’s trip to the UBS Global Healthcare Conference ain’t just another checkbox on a corporate to-do list. It’s where the nitty-gritty of their strategy reveals itself, as Bob VanHimbergen and Bobby Modi step into the spotlight on November 9. While not everyone's shouting...

Continue Reading
NJ Small Businesses: Free IT Security Checks Offered

Updated Category News Views 116

Unpacking Corporate Technologies' Offer It's not every day a company doles out free consultations, but Corporate Technologies is doing just that. They're tossing New Jersey's small-to-mid businesses a lifeline with free IT and cybersecurity assessments. There's no catch, just thirty minutes of pure, no-nonsense evaluation of your tech setup. Couldn’t hurt to know where...

Continue Reading
XPLR Infrastructure Posts Solid Q3 Results, Eyes Growth

Updated Category News Views 104

Third Quarter Results: Crunching the Numbers Every season brings new tidbits, and when XPLR Infrastructure, LP (NYSE: XIFR) dropped their third-quarter 2026 results, you bet I was ready with my magnifying glass. November 3rd was the day to circle on your calendars, as the folks over at Juno Beach sure had something to say. They’ve plastered the details across their...

Continue Reading
Mothers® Unveils New Wheel & Tire Care Products

Updated Category News Views 34

Revamping Auto Care: The New Products from Mothers® Diving headfirst into the glossy world of wheel and tire care is Mothers®, armed with two fresh products: Spray & Shine All Wheel Cleaner and Back-to-Black® Extreme Tire Shine. These aren’t just any off-the-shelf quick fixes—they’re born out of over half a century of relentless pursuit of vehicular perfection....

Continue Reading
CStone, Kimia Collaboration Targets Solid Tumor Survival

Updated Category News Views 74

Biotech Giants CStone and Kimia Unite Forces In the heart of China's biotechnology scene, the latest collaboration news to hit the wires is CStone Pharmaceuticals shaking hands with Kimia Therapeutics. Now, don't go tossing this aside as another run-of-the-mill partnership announcement. CStone's HKEX: 2616 ticker has got its eyes locked on an ambitious dance with Kimia,...

Continue Reading
EXPO 2027 Belgrade: Serbia's Tourism Game-Changer?

Updated Category News Views 15

An Unexpected Stage: Belgrade's Big Show Well, who's betting on Belgrade making waves in the global travel scene? EXPO 2027 is shaping up to do just that, and it’s taking the scenic route. Serbia, a country not always on the grand tourist itineraries, could finally hog the spotlight come 2027. Under the banner of 'Play for Humanity: Sport and Music for All,' they're...

Continue Reading
OSL Unveils Instant Redemption for USDGO Plus SP

Updated Category News Views 107

OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Blue Shield of California Gains Praise for Health Equity Efforts

Updated Category News Views 173

Blue Shield of California's Commitment to Health Equity Blue Shield of California, a renowned nonprofit health plan, serves 6 million members across its state. Recently, it has garnered nationwide recognition for its exceptional dedication to health equity and its efforts to enhance access to culturally relevant care. The nonprofit health plan achieved a perfect score in...

Continue Reading
Onconetix and Ocuvex Conclude Merger Agreement: What's Next?

Updated Category News Views 139

Onconetix and Ocuvex Announce Merger Agreement Termination Two pioneering companies, Onconetix, Inc. (Nasdaq: ONCO) and Ocuvex Therapeutics, have chosen to part ways, terminating their merger agreement originally dated July 16, 2025. This decision comes after extensive dialogue and consideration, reflecting both companies' dedication to their missions and the stakeholders...

Continue Reading
FedEx Partners with Nimble to Enhance Supply Chain Efficiency

Updated Category News Views 101

FedEx Boosts Supply Chain with Investment in Nimble FedEx (NYSE: FDX) has made an exciting announcement regarding its investment in Nimble, a company that specializes in AI robotics and autonomous technologies. This strategic decision is aimed at enhancing the capabilities of FedEx's Fulfillment division, which focuses on supporting small and medium-sized businesses with...

Continue Reading
CNC Controller Market Forecast: $7.2 Billion by 2033

Updated Category News Views 121

Growth Projections for the CNC Controller Market The global CNC controller market is witnessing impressive growth, driven by several important factors, particularly the increasing automation in manufacturing. This need for efficiency and precision has stimulated the demand across multiple sectors, particularly the aerospace industry, ensuring CNC controllers are at the...

Continue Reading
Innovative Collaboration to Develop Keytruda Biosimilar by Alvotech

Updated Category News Views 212

Collaboration Between Alvotech and Dr. Reddy’s Laboratories In an exciting new partnership, Alvotech, a leading global biotech company known for its pioneering work in biosimilar medicines, has teamed up with Dr. Reddy’s Laboratories to co-develop a biosimilar candidate aimed at replicating Keytruda, whose generic name is pembrolizumab. This therapeutic is widely...

Continue Reading